#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	27584	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2062	1320.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1712	1712	T	1512	T,C,A	1378,71,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	27584	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2062	1320.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	1490	C	1449	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	51168	23S	2890	2890	99.97	23S.l6.c30.ctg.1	3532	1434.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	1576	C,A	1526,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	51168	23S	2890	2890	99.97	23S.l6.c30.ctg.1	3532	1434.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	1624	A,C	1584,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	51168	23S	2890	2890	99.97	23S.l6.c30.ctg.1	3532	1434.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	1533	C	1496	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	128382	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1595	5631.9	0	.	p	.	0	M180T	NONSYN	538	540	ATG	902	904	ACG	7920;7898;7878	A,C,G;C,T,A,G;G,A	7694,2,1;7764,5,6,3;7732,3	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	3724	folP	855	855	100.0	folP.l15.c4.ctg.1	1515	243.2	1	SNP	p	R229S	1	.	.	685	687	AGC	957	959	AGC	363;362;363	A;G;C	353;353;352	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3459	293.9	1	SNP	p	S91F	1	.	.	271	273	TTC	640	642	TTC	324;322;325	T;T,C;C	319;312,4;320	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3459	293.9	1	SNP	p	D95G	1	.	.	283	285	GGC	652	654	GGC	320;320;323	G;G,A;C	315;312,3;318	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3459	293.9	1	SNP	p	G95N	0	.	.	283	285	GGC	652	654	GGC	320;320;323	G;G,A;C	315;312,3;318	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	539	2962	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1247	235.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	418	420	ACC	374;372;372	A,G;C;C	336,17;358;360	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1738	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	900	190.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	0	.	p	.	0	E91G	NONSYN	271	273	GAG	578	580	GGG	330;332;329	G;G,A,T;G	326;318,10,1;324	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1457	1459	ATC	364;363;362	A,G;T;C,T	342,13;356;357,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1610	1612	GCA	362;356;358	G,T;C,T,G;A,G	349,2;315,11,1;325,12	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	1	SNP	p	D86N	0	.	.	256	258	GAC	563	565	GAC	326;326;329	G;A;C	322;317;321	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	1	SNP	p	S87W	0	.	.	259	261	AGT	566	568	AGT	328;331;331	A,C;G;T	315,5;329;323	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	1	SNP	p	S87I	0	.	.	259	261	AGT	566	568	AGT	328;331;331	A,C;G;T	315,5;329;323	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	1	SNP	p	S87R	0	.	.	259	261	AGT	566	568	AGT	328;331;331	A,C;G;T	315,5;329;323	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	8834	parC	2304	2304	99.7	parC.l6.c17.ctg.1	2905	300.9	1	SNP	p	S88P	0	.	.	262	264	TCC	569	571	TCC	331;333;333	T;C,A;C	323;326,1;329	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	7604	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2605	289.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1586	1588	GGC	372;364;361	G;G;C,G	367;359;349,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1262	1264	GCA	423;421;424	G,T;C,G;A,C	407,1;403,1;402,7	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1265	1267	ATC	429;430;431	A;T;C,G	412;414;407,7	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1277	1279	GTG	426;424;426	G,A;T,C,A;G,C,T	406,3;398,3,1;409,2,1	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1277	1279	GTG	426;424;426	G,A;T,C,A;G,C,T	406,3;398,3,1;409,2,1	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1781	1783	ACC	335;329;329	A;C;C	311;318;320	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1835	1837	GCG	303;304;305	G;C,G;G	288;258,8;294	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1835	1837	GCG	303;304;305	G;C,G;G	288;258,8;294	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1958	1960	GGC	292;290;289	G;G;C,T	279;280;266,6	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1967	1969	GGC	282;279;270	G,A,T;G;C	255,6,1;263;251	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	7258	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2350	302.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1985	1987	CCG	219;221;214	C,G;C;G,C	212,1;210;189,3	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	10656	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3162	333.8	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1515	1517	ACG	369;369;370	A,G,C;C,A;G	336,15,1;350,1;353	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	10656	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3162	333.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1653	1655	CTG	347;346;342	C,T;T,C,G;G	321,1;323,9,1;323	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4520	porA	1146	1146	99.56	porA.l15.c30.ctg.1	1643	270.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	313	315	GGC	307;306;305	G,A;G;C	292,5;294;293	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4520	porA	1146	1146	99.56	porA.l15.c30.ctg.1	1643	270.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	282	C,G	260,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	552	porB1a	984	174	93.1	porB1a.l15.c4.ctg.3	175	2.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	39	41	GTA	2;2;2	G;T;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	552	porB1a	984	174	93.1	porB1a.l15.c4.ctg.3	175	2.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	99	101	ACT	4;4;4	A;C;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	552	porB1a	984	174	93.1	porB1a.l15.c4.ctg.3	175	2.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	105	107	GAT	4;4;4	G;A;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	552	porB1a	984	174	93.1	porB1a.l15.c4.ctg.3	175	2.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	114	116	AAC	4;4;4	A;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	552	porB1a	984	174	93.1	porB1a.l15.c4.ctg.3	175	2.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	117	119	CAC	4;4;4	C;A;C	3;3;3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	D41K	NONSYN	121	123	GAC	575	577	AAA	393;389;393	A,G;A;A	376,9;380;384	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	V75I	NONSYN	223	225	GTT	677	679	ATT	394;394;392	A,G;T;T	383,1;378;382	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	719	721	AGC	403;399;405	A;G,C;C,T	391;390,4;394,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	845	847	TAT	399;401;403	T;A,T;T	388;387,7;390	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	854	856	GAG	412;412;414	G,A,T;A;G,T	391,5,1;396;395,4	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	V135F	NONSYN	403	405	GTG	857	859	TTT	413;413;416	T,G;T;T,G	378,5;400;398,5	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	872	874	AAA	403;401;402	A,G;A,G;A	385,7;384,7;390	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	881	883	CAA	407;402;405	C,A,T;A,G;A	388,8,1;383,7;392	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1013	1015	CGA	409;407;404	C;G,A;A	399;401,1;396	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	0	.	p	.	0	S189N	NONSYN	565	567	AGC	1019	1021	AAC	419;422;427	A,G;A,G;C,T	411,2;407,3;419,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	5262	porB1b	1047	1047	97.9	porB1b.l15.c17.ctg.1	1644	316.7	1	SNP	p	G120K	0	.	.	358	360	GGC	812	814	GGC	394;386;384	G,A;G,A;C,G,T	375,5;373,5;368,5,4	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	19080	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4962	380.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2035	2037	AAT	413;410;411	A,C;A;T	399,10;407;405	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	2048	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1046	193.7	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	405;406;408	A;T;G,A	401;399;401,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
